2013 Clinical Issues in HIV Medicine

A PDF reader is required to view this content.

Introduction

Advances Continue to Improve HIV Care and Opportunities for Prevention, But Funding Climate Threatens Progress Against Epidemic

Author(s): Kenneth H. Mayer and Daniel R. Kuritzkes

pp. 3-9

Detection of Acute HIV Infection: A Field Evaluation of the Determine^® HIV-1/2 Ag/Ab Combo Test

Author(s): Nora E. Rosenberg, Gift Kamanga, Sam Phiri, Dominic Nsona, Audrey Pettifor, Sarah E. Rutstein, Deborah Kamwendo, Irving F. Hoffman, Maria Keating, Lillian B. Brown, Beatrice Ndalama, Susan A. Fiscus, Seth Congdon, Myron S. Cohen, and William C. Miller

pp. 10-13

Editorial Commentary: Detection of Acute HIV Infection: We Can’t Close the Window

Author(s): Bernard M. Branson and Joanne D. Stekler

pp. 14-22

Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Author(s): Timothy J. Henrich, Zixin Hu, Jonathan Z. Li, Gaia Sciaranghella, Michael P. Busch, Sheila M. Keating, Sebastien Gallien, Nina H. Lin, Francoise F. Giguel, Laura Lavoie, Vincent T. Ho, Philippe Armand, Robert J. Soiffer, Manish Sagar, Ann S. LaCasce, and Daniel R. Kuritzkes

pp. 23-31

Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis

Author(s): J. Troy Grennan, Mona R. Loutfy, DeSheng Su, P. Richard Harrigan, Curtis Cooper, Marina Klein, Nima Machouf, Julio S. G. Montaner, Sean Rourke, Christos Tsoukas, Bob Hogg, Janet Raboud, and the CANOC Collaboration

pp. 32-34

Editorial Commentary: More Reasons to Reexamine the Definition of Viral Blip During Antiretroviral Therapy

Author(s): Babafemi Taiwo and Ronald J. Bosch

pp. 35-42

The Effect of a “Universal Antiretroviral Therapy” Recommendation on HIV RNA Levels Among HIV-Infected Patients Entering Care With a CD4 Count Greater Than 500/µL in a Public Health Setting

Author(s): Elvin H. Geng, C. Bradley Hare, James O. Kahn, Vivek Jain,Tracy Van Nunnery, Katerina A. Christopoulos, Steven G. Deeks, Monica Gandhi, and Diane V. Havlir

pp. 43-46

Is Frequent CD4+ T-Lymphocyte Count Monitoring Necessary for Persons With Counts ≥300 Cells/µL and HIV-1 Suppression?

Author(s): Howard B. Gale, Steven R. Gitterman, Heather J. Hoffman, Fred M. Gordin, Debra A. Benator, Ann M. Labriola, and Virginia L. Kan

pp. 47-49

Editorial Commentary: Can We Break the Habit of Routine CD4 Monitoring in HIV Care?

Author(s): Paul E. Sax

pp. 50-58

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

Author(s): Joseph J. Eron, Bonaventura Clotet, Jacques Durant, Christine Katlama, Princy Kumar, Adriano Lazzarin, Isabelle Poizot-Martin, Gary Richmond, Vincent Soriano, Mounir Ait-Khaled, Tamio Fujiwara, Jenny Huang, Sherene Min, Cindy Vavro, and Jane Yeo, for the VIKING Study Group

pp. 59-68

Influence of Geographical Origin and Ethnicity on Mortality in Patients on Antiretroviral Therapy in Canada, Europe, and the United States

Author(s): The Antiretroviral Therapy Cohort Collaboration (ART-CC)

pp. 69-70

Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient

Author(s): Kimberly Y. Smith

pp. 71-81

Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Study

Author(s): Lene Ryom, Amanda Mocroft, Ole Kirk, Signe W. Worm, David A. Kamara, Peter Reiss, Michael Ross, Christoph A. Fux, Philippe Morlat, Olivier Moranne, Colette Smith, Jens D. Lundgren, on behalf of the D:A:D Study Group

pp. 82-84

Editorial Commentary: Nephrotoxicity of Antiretroviral Agents: Is the List Getting Longer?

Author(s): Derek M. Fine and Joel E. Gallant

pp. 85-94

Combination Antiretroviral Use and Preterm Birth

Author(s): D. Heather Watts, Paige L. Williams, Deborah Kacanek, Raymond Griner, Kenneth Rich, Rohan Hazra, Lynne M. Mofenson, and Hermann A. Mendez, for the Pediatric HIV/AIDS Cohort Study

pp. 95-105

Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana

Author(s): Jennifer Y. Chen, Heather J. Ribaudo, Sajini Souda, Natasha Parekh, Anthony Ogwu, Shahin Lockman, Kathleen Powis, Scott Dryden-Peterson, Tracy Creek, William Jimbo, Tebogo Madidimalo, Joseph Makhema, Max Essex, and Roger L. Shapiro

pp. 106-108

Editorial Commentary: Antiretrovirals in Pregnancy: A Note of Caution

Author(s): D. Heather Watts and Lynne M. Mofenson

pp. 109-119

Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Author(s): Mark J. Abzug, Min Qin, Myron J. Levin, Terence Fenton, Judy A. Beeler, William J. Bellini, Susette Audet, Sun Bae Sowers, William Borkowsky, Sharon A. Nachman, Stephen I. Pelton, and Howard M. Rosenblatt, for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams

pp. 120-122

Editorial Commentary: Measles Vaccine, HIV Infection, and Antiretroviral Therapy—A Window of Opportunity

Author(s): Yvonne Maldonado

pp. 123-130

Vitamin D Status and Incidence of Pulmonary Tuberculosis, Opportunistic Infections, and Wasting Among HIV-Infected Tanzanian Adults Initiating Antiretroviral Therapy

Author(s): Christopher R. Sudfeld, Edward L. Giovannucci, Sheila Isanaka, Said Aboud, Ferdinand M. Mugusi, Molin Wang, Guerino Chalamilla, and Wafaie W. Fawzi

pp. 131-133

Editorial Commentary: Vitamin D: An Adjunct to Antiretroviral Therapy?

Author(s): Adrian R. Martineau

pp. 134-143

An Updated Systematic Review and Meta-analysis on the Treatment of Active Tuberculosis in Patients With HIV Infection

Author(s): Faiz Ahmad Khan, Jessica Minion, Abdullah Al-Motairi, Andrea Benedetti, Anthony D. Harries, and Dick Menzies

pp. 144-151

The Rising Challenge of Non–AIDS-Defining Cancers in HIV-Infected Patients

Author(s): John F. Deeken, Angelique Tjen-A-Looi, Michelle A. Rudek, Catherine Okuliar, Mary Young, Richard F. Little, and Bruce J. Dezube

pp. 152-159

Mortality in Hepatitis C Virus–Infected Patients With a Diagnosis of AIDS in the Era of Combination Antiretroviral Therapy

Author(s): Andrea D. Branch, Mark L. Van Natta, Marie-Louise Vachon, Douglas T. Dieterich, Curtis L. Meinert, and Douglas A. Jabs, for the Studies of the Ocular Complications of AIDS Research Group

pp. 160-173

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

Author(s): The Mind Exchange Working Group

pp. 174-181

Effects of Smoking on Non-AIDS Related Morbidity in HIV-Infected Patients

Author(s): Daniel K. Shirley, Robert J. Kaner, and Marshall J. Glesby

pp. 182-191

Improvement in the Health of HIV-Infected Persons in Care: Reducing Disparities

Author(s): Richard D. Moore, Jeanne C. Keruly, and John G. Bartlett

pp. 192-194

Editorial Commentary: Viva No Différence!

Author(s): Michael S. Saag

pp. 195-205

A Low-Effort, Clinic-Wide Intervention Improves Attendance for HIV Primary Care

Author(s): Lytt I. Gardner, Gary Marks, Jason A. Craw,Tracey E. Wilson, Mari-Lynn Drainoni, Richard D. Moore, Michael J. Mugavero, Allan E. Rodriguez, Lucy A. Bradley-Springer, Susan Holman, Jeanne C. Keruly, Meg Sullivan, Paul R. Skolnik, Faye Malitz, Lisa R. Metsch, James L. Raper, and Thomas P. Giordano, for the Retention in Care Study Group

pp. 206-213

Sexual Risk Behavior Among Youth With Perinatal HIV Infection in the United States: Predictors and Implications for Intervention Development

Author(s): Katherine Tassiopoulos, Anna-Barbara Moscicki, Claude Mellins, Deborah Kacanek, Kathleen Malee, Susannah Allison, Rohan Hazra, George K. Siberry, Renee Smith, Mary Paul, Russell B. Van Dyke, and George R. Seage III, for the Pediatric HIV/AIDS Cohort Study

2013 Clinical Issues in HIV Medicine

HIV Medicine Association